These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 8070016

  • 21. DNA topoisomerase-targeting antitumor drugs can be studied in yeast.
    Nitiss J, Wang JC.
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7501-5. PubMed ID: 2845409
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A novel mutation in DNA topoisomerase I of yeast causes DNA damage and RAD9-dependent cell cycle arrest.
    Levin NA, Bjornsti MA, Fink GR.
    Genetics; 1993 Apr; 133(4):799-814. PubMed ID: 8385050
    [Abstract] [Full Text] [Related]

  • 31. Platinated DNA adducts enhance poisoning of DNA topoisomerase I by camptothecin.
    van Waardenburg RC, de Jong LA, van Eijndhoven MA, Verseyden C, Pluim D, Jansen LE, Bjornsti MA, Schellens JH.
    J Biol Chem; 2004 Dec 24; 279(52):54502-9. PubMed ID: 15471886
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Cloning of yeast TOP1, the gene encoding DNA topoisomerase I, and construction of mutants defective in both DNA topoisomerase I and DNA topoisomerase II.
    Goto T, Wang JC.
    Proc Natl Acad Sci U S A; 1985 Nov 24; 82(21):7178-82. PubMed ID: 2997777
    [Abstract] [Full Text] [Related]

  • 35. Differential expression of topoisomerase I and RAD52 protein in yeast reveals new facets of the mechanism of action of bisdioxopiperazine compounds.
    van Hille B, Clerc X, Creighton AM, Hill BT.
    Br J Cancer; 1999 Nov 24; 81(5):800-7. PubMed ID: 10555749
    [Abstract] [Full Text] [Related]

  • 36. A specific transcriptional response of yeast cells to camptothecin dependent on the Swi4 and Mbp1 factors.
    Lotito L, Russo A, Bueno S, Chillemi G, Fogli MV, Capranico G.
    Eur J Pharmacol; 2009 Jan 28; 603(1-3):29-36. PubMed ID: 19094980
    [Abstract] [Full Text] [Related]

  • 37. The human topoisomerase 1B Arg634Ala mutation results in camptothecin resistance and loss of inter-domain motion correlation.
    D'Annessa I, Tesauro C, Wang Z, Arnò B, Zuccaro L, Fiorani P, Desideri A.
    Biochim Biophys Acta; 2013 Dec 28; 1834(12):2712-21. PubMed ID: 24096022
    [Abstract] [Full Text] [Related]

  • 38. Differential poisoning of human and Aspergillus nidulans DNA topoisomerase I by bi- and terbenzimidazoles.
    Goldman GH, Yu C, Wu HY, Sanders MM, La Voie EJ, Liu LF.
    Biochemistry; 1997 May 27; 36(21):6488-94. PubMed ID: 9174366
    [Abstract] [Full Text] [Related]

  • 39. Repair of topoisomerase I covalent complexes in the absence of the tyrosyl-DNA phosphodiesterase Tdp1.
    Liu C, Pouliot JJ, Nash HA.
    Proc Natl Acad Sci U S A; 2002 Nov 12; 99(23):14970-5. PubMed ID: 12397185
    [Abstract] [Full Text] [Related]

  • 40. Active site mutations in DNA topoisomerase I distinguish the cytotoxic activities of camptothecin and the indolocarbazole, rebeccamycin.
    Woo MH, Vance JR, Marcos AR, Bailly C, Bjornsti MA.
    J Biol Chem; 2002 Feb 08; 277(6):3813-22. PubMed ID: 11733535
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.